TNF- inhibits insulin action in liver and adipose tissue: A model of metabolic syndrome

Hormone and Metabolic Research

Volumn 42, Issue 2, 2010, Pages 115-121

  Solomon, S S ^a   Odunusi, O ^a   Carrigan, D ^a   Majumdar, G ^a   Kakoola, D ^a   Lenchik, N I ^a   Gerling, I C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Apoptosis; Energy utilization; Genomics; Insulin; Liver cells; Metabolic syndrome model; Phosphorylation; Receptor and signaling; Tissue culture

Indexed keywords

CASPASE 3; GUANINE NUCLEOTIDE BINDING PROTEIN; INFLIXIMAB; INSULIN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE 14; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMAD PROTEIN; STAT1 PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; HYPERGLYCEMIC AGENT; MESSENGER RNA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; LIVER; LIVER CELL; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

RATTUS;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; GENE EXPRESSION PROFILING; INSULIN; INSULIN ANTAGONISTS; INSULIN RESISTANCE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; METABOLIC SYNDROME X; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76149109500     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1241834     Document Type: Article

References (40)

1. Eckel J, Asskamp B, Reinauer H. Induction of insulin resistance in primary cultured adult cardiamyocytes. Endocrinology 1991 29 345-352
2. Piccini JP, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 2004 116 (Suppl 5A) 645-675S
3. Nesto RW. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association: Response to Elasy and Griffin. Diabetes Care 2004 27 2096
4. Sobel BE. Insulin resistance predicts CHF (Ed). Clinical Insights in Diabetes 2005 8 2
5. Ingelsson, E, Sundstrm J, Arnlv J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. J Am Med Assoc 2005 294 334-341 (Pubitemid 41043777)
6. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers AC. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes 1980 29 906-910
7. Shankar TP, Solomon SS, Duckworth WC, Himmelstein S, Gray S, Jerkins T, Babal MA, Ramamurthy SI. Studies of glucose intolerance in cirrhosis of the liver. J Lab Clin Med 1983 102 459-469
8. Shankar TP, Fredi JL, Himmelstein S, Solomon SS, Duckworth WC. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the Liver. Am J Med Sci 1986 291 248-254
9. Shankar TP, Solomon SS, Duckworth WC, Jerkins T, Iyer RS, Bobel MA. Growth Hormone and carbohydrate intolerance in cirrhosis. Horm Metab Res 1988 20 579-583
10. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002 109 1321-1326
11. Hotamisligl GS. Inflammatory pathways and insulin action. Int J Obes Rel Metab Disord 2003 27 (Suppl 3) 553-555
12. Hotamisligil GS. Mechanisms of TNF- induced insulin resistance. Exp Clin Endocrinol Diabetes 1999 107 119-125
13. Hotamisligil GS, Johnson RS, Distel RJ, Ellis, R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996 274 1377-1379
14. Kirwan, JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Houston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNA- is a predictor of insulin resistance in human pregnancy. Diabetes 2002 51 2207-2213
15. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994 31 1188-1193
16. Ruan H, Miles PD, Ladd CM, Ross K, Golub TR, Olefsky JM, Lodish HF. Profiling gee transcription in vivo reveals adipose tissue as an immediate target of TNF- Diabetes 2002 51 3176-3188
17. Hotamisligil GS, Arne P, Caro JF, Atkinson RL. Speigelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995 95 2409-2414
18. Kern PA, Sagizadeh M, Ong JM, Bosch RJ, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 1995 95 2111-2119
19. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH, Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: Evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 1998 139 4928-4935
20. Hotamisligil GS, Perald, P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF- and obesity-induced insulin resistance. Science 1996 271 665-668
21. Solomon SS, Buss N, Shull J, Monnier S, Majumdar G, Wu J, Gerling IC. Proteome of H-411E (liver) cells exposed to insulin and TNF-: Analysis of proteins involved in insulin resistance. J Lab Clin Med 2005 145 275-283
22. Solomon SS, Mishra SK, Cwik C, Rajanna B, Postlethwaite AE. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells. Horm Metab Res 1997 29 379-382
23. Peraldi P, Hotamisligil GS, Burman WA, White MF, Spiegelman BM. Tumor necrosis factor-alpha (TNF-) inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomylenase. J Biol Chem 1996 271 13018-130122
24. Solomon SS, Mishra SK, Palazzolo MR, Postlethwaite AE, Seyer JM. Identification of specific sites in the TNF- molecule promoting insulin resistance in H-411E cells. J Lab Clin Med 1997 130 139-146
25. Pang Y, Zheng B, Fan LW, Rhodes PG, Cai Z. IGF-1 protects oligodendrocyte progenitors against TNF- induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia 2007 55 1099-1107
26. Gerling IC, Singh S, Lenchik NI, Marshall DR, Wu J. New data-analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol Cell Proteomics 2006 5 293-305
27. Gadgill HS, Pabst KM, Giorgianni F, Umstot ES, Desiderio DM, Beranova-Giorgianni S, Gerling IC, Pabst MJ. Proteome of monocytes primed with lipopolysacharide: Analysis of the abundant proteins. Proteomics 2003 3 1767-1780
28. Gerling IC, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, Postlethwaite AE, Weber KT. Aldosteronism: An immunostimulatory state precedes the pro inflammatory/fibrogenic cardiac phenotype. Amer. J Physiol- Heart C 2003 285 H813-H821
29. Aniquichi CM, Tran TT, Kondo T, Luo J, Veki K, Cauley LC, Kahn CR. PI3 Kinase regulatory subunit P85 suppresses insulin via positive regulation of PTEN. Proc Natl Acad Sci U S A 2006 103 12093-12097
30. Gustin JA, Machama T, Dixon TE, Donner DB. The PTEN suppressor protein inhibits TNF-induced NFK activity. J Biol Chem 2001 276 27740-27744
31. Araújo EP, De Souza CT, Ueno, Mcintra DE, Bertolo MB, Carvalheira JB, Mário J, Velloso LA. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 2007 148 5991-5997
32. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006 119 S10-S16
33. Perseghi G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance; potential links with inflammation. Int J Obes Relat Metab Disord 2003 27 (Suppl 3) S6-S11
34. Petersen KF, Hendler R, Price T, Perseghin G, Rothman DL, Heid N, Amatruda JM, Shulman GI. 13C/31P NMR studies on the mechanism of insulin resistance in Obesity. Diabetes 1998 47 381-386
35. Steinberg GR, Mitchell BJ, Van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrickopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE. Tumor necrosis factor-alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 2006 4 465-474
36. Befroy DE, Petersen KF, Dufour S, Mason GF, DeFraaf RA, Rothman DL, Shulman GI. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of Type 2 diabetic patients. Diabetes 2007 56 1376-1381
37. Nishikawa T, Aroki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antoxid Redox Signal 2007 9 343-353 (Pubitemid 46150966)
38. Imoto K, Kukidome D, Nishikawa T, Matsuhisa T, Sonoda K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Tsuruzoe K. Impact of mitochondrial reactive oxygen species and apoptosis signal regulating kinase 1 on insulin signaling. Diabetes 2006 55 1197-1204
39. James KA, Albeck JG, Gaudet S, Sorger PK, Lauftenburger DA, Yatte MD. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005 310 1646-1653
40. Qin B, Dawson H, Polansky MM, Anderson RA. Cinnamon extract attenuates TNF - induced Intestinal lipoprotein Apo B48 overproduction by regulating inflammatory, insulin, and lipoprotein pathways in enterocytes. Horm Metab Res 2009 41 516-522